查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2029983

全球血栓抽吸導管市場：按產品類型、應用、最終用途和地區分類－市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Thrombus Aspiration Catheter Market: By Product Type, Application, End-Use, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 280 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球血栓抽吸導管市場正經歷強勁且持續的成長，反映出臨床對先進介入心臟病學器材的需求日益成長。預計2025年市場規模約為22.5億美元，並在未來十年內顯著擴張，到2035年將達到約48.6億美元。此成長意味著2026年至2035年預測期間的複合年成長率約為8%，顯示該技術在已開發醫療體系和新興醫療體系中均已穩定應用。

這一成長主要受全球心血管疾病負擔日益加重的驅動。心血管疾病仍然是全球發病率和死亡率的主要原因之一。隨著急性冠狀動脈症候群、心肌梗塞和中風等疾病發生率的上升，介入手術中快速有效管理血栓的需求也日益成長。因此，醫療專業人員擴大將血栓抽吸導管納入其在急診和高風險心血管護理環境中的標準工具包中。

顯著的市場趨勢

血栓抽吸導管市場的競爭格局高度集中，主要呈現寡占格局。少數幾家全球大型醫療設備公司憑藉強大的智慧財產權組合、廣泛的分銷網路以及在研發方面的大量投入，主導著該行業。因此，一級廠商佔了全球市場佔有率的約65%至70%。

在領先的一級醫療器材公司中，Medtronic憑藉其廣泛的心血管產品組合和強大的全球影響力，在全球血栓抽吸導管市場中佔主導地位。波士頓科學也是其主要競爭對手，該公司以開發優先考慮卓越循跡性和手術效率的器械而聞名，這在複雜的介入手術中至關重要。同時，Terumo Corporation憑藉其成熟的分銷管道和在精密導管技術方面的良好聲譽，在亞太和歐洲地區保持強大的市場地位。

除了這些主要廠商之外，二線廠商約佔全球市場佔有率的30%至35%。這些廠商通常透過採取更積極的定價策略或專注於滿足特定手術需求的專業利基技術來競爭。例如，Teleflex公司在專業導管領域佔了穩固的地位，為介入性心臟病學提供針對性的解決方案。同樣，Merit Medical Systems和Vascular Solutions等公司的傳統技術也持續提供可靠且經濟高效的手動吸引系統。

主要成長要素

中風和冠狀動脈疾病發生率的不斷上升，是推動有效急性介入器材（例如血栓抽吸導管）需求成長的主要因素。隨著這些疾病在全球範圍內持續增加，醫療系統越來越依賴快速、微創的手術來應對危及生命的心血管事件。這凸顯了導管介入治療在緊急心臟護理中的作用，因為快速恢復血流對於患者的生存和康復至關重要。

新機會的趨勢

血栓抽吸導管市場的發展受到醫療保健領域整體投資趨勢和臨床重點轉變的雙重驅動。全球醫療系統日益關注效率、治療效果和成本控制，這使得能夠簡化流程、改善患者復健的技術變得愈發重要。經濟壓力與臨床需求的這種契合，為血栓切除解決方案的推廣應用創造了有利環境。

最佳化障礙

血栓抽吸術的常規早期應用尚未得到普遍認可，這種猶豫不決持續阻礙因素市場成長。儘管該技術在某些情況下有益，但由於臨床結果不一以及對潛在手術風險的擔憂，將其常規應用於所有接受經皮冠狀動脈介入治療（PCI）的患者仍存在爭議。因此，許多臨床醫生傾向於採取更具選擇性的方法，或僅在緊急情況下使用血栓抽吸術，而不是將其作為所有病例的一線標準治療方法。

目錄

第1章摘要整理：全球血栓抽吸導管市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：按地區分類
  • 本研究的前提
  • 市場規模估算
  • 數據三角測量

第3章：全球血栓抽吸導管市場概述

  • 產業價值鏈分析
  • 產業展望
    • 心血管疾病（CVD）盛行率增加
    • 經經皮冠狀動脈介入治療（PCI）例數增加。
    • 微創手術的廣泛應用
    • 導管設計方面的技術進步
    • 快速血栓除去裝置的需求日益成長
    • 新興市場醫療保健基礎設施的擴建
    • 人口老化的過程
  • PESTLE分析
  • 波特五力分析
  • 市場動態和趨勢
    • 成長要素
      • 血栓相關疾病負擔加重，推動了市場需求。
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場成長及前景
    • 市場規模估算與預測（收入和銷售），2020-2035年
    • 價格趨勢分析：依原料分類

第4章：競爭對手儀表板

  • 市場集中度
  • 企業市場占有率分析，2025 年
  • 競爭對手分析與基準測試
  • 創業生態系分析
  • 併購和資金籌措趨勢

第5章：全球血栓抽吸導管市場分析

  • 關鍵見解
  • 市場規模及預測，2020-2035年
    • 依產品類型
      • 手動吸管
      • 機械吸管
      • 電動吸管
    • 用途別
      • 急性冠狀動脈症候群（ACS）
      • 肺動脈栓塞（PE）
      • 深層靜脈栓塞症（DVT）
      • 缺血性中風
      • 其他
    • 按最終用途
      • 醫院
      • 循環系統中心
      • 門診手術中心（ASC）
      • 其他
    • 按地區
      • 北美洲
        • 美國
        • 加拿大
        • 墨西哥
      • 歐洲
        • 西歐
          • 英國
          • 德國
          • 法國
          • 義大利
          • 西班牙
          • 其他西歐國家
        • 東歐
          • 波蘭
          • 俄羅斯
          • 其他東歐國家
      • 亞太地區
        • 中國
        • 印度
        • 日本
        • 韓國
        • 澳洲和紐西蘭
        • ASEAN
          • 印尼
          • 馬來西亞
          • 泰國
          • 新加坡
          • 其他東南亞國協
        • 其他亞太國家
      • 中東和非洲
        • UAE
        • 沙烏地阿拉伯
        • 南非
        • 其他中東和非洲國家
      • 南美洲
        • 阿根廷
        • 巴西
        • 其他南美國家

第6章：北美血栓抽吸導管市場分析

第7章：歐洲血栓抽吸導管市場分析

第8章：亞太地區血栓抽吸導管市場分析

第9章：中東和非洲血栓抽吸導管市場分析

第10章：南美洲血栓抽吸導管市場分析

第11章：公司簡介

  • AMG International
  • Biotronik
  • Endocor
  • Eucatech
  • Medtronic plc
  • HEXACATH
  • Nipro
  • SAI Infusion Technologies
  • Stentys
  • Teleflex
  • Boston Scientific Corporation
  • Terumo Corporation
  • Penumbra Inc.
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Abbott Laboratories
  • Johnson & Johnson MedTech
  • AngioDynamics Inc.
  • Inari Medical Inc.
  • Other Prominent Players

第12章附錄

簡介目錄
Product Code: AA04261765

The global thrombus aspiration catheter market is experiencing strong and sustained growth, reflecting the increasing clinical demand for advanced cardiovascular intervention tools. In 2025, the market was valued at approximately USD 2.25 billion, and it is expected to expand significantly over the coming decade, reaching an estimated USD 4.86 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of around 8% during the forecast period from 2026 to 2035, indicating steady adoption across both developed and emerging healthcare systems.

This expansion is primarily being driven by the rising global burden of cardiovascular diseases, which continue to be a leading cause of morbidity and mortality worldwide. The increasing incidence of conditions such as acute coronary syndrome, myocardial infarction, and stroke has intensified the need for rapid and effective thrombus management during interventional procedures. As a result, healthcare providers are increasingly adopting thrombus aspiration catheters as part of their standard toolkit in emergency and high-risk cardiovascular care settings.

Noteworthy Market Developments

The competitive landscape of the thrombus aspiration catheter market is highly consolidated and functions largely as an oligopolistic structure. A small group of major global medical device companies dominates the industry, supported by strong intellectual property portfolios, extensive distribution networks, and substantial investments in research and development. As a result, Tier 1 players collectively control an estimated 65% to 70% of the global market share.

Among the leading Tier 1 participants, Medtronic stands out as a dominant force in the global thrombus aspiration catheter market, supported by its broad cardiovascular portfolio and strong global reach. Boston Scientific is another major competitor, known for developing devices that emphasize superior trackability and procedural efficiency, which are critical in complex interventional cases. Meanwhile, Terumo Corporation maintains a particularly strong presence in the Asia Pacific and European regions, benefiting from its established distribution channels and reputation for precision catheter technologies.

Alongside these leaders, Tier 2 companies collectively account for approximately 30% to 35% of the global market. These firms typically compete through more aggressive pricing strategies or by focusing on specialized niche technologies that cater to specific procedural needs. Companies such as Teleflex Incorporated have developed a strong foothold in the specialized catheter segment, offering targeted solutions for interventional cardiology. Similarly, Merit Medical Systems and legacy technologies from Vascular Solutions continue to provide reliable and cost-effective manual aspiration systems.

Core Growth Drivers

The growing prevalence of stroke and coronary artery disease is a major factor driving demand for effective acute interventional devices such as thrombus aspiration catheters. As these conditions continue to rise globally, healthcare systems are increasingly relying on rapid, minimally invasive procedures to manage life-threatening cardiovascular events. This has strengthened the role of catheter-based interventions in emergency cardiac care, where timely restoration of blood flow is critical for patient survival and recovery.

Emerging Opportunity Trends

The thrombus aspiration catheter market is being driven by a combination of broader healthcare investment trends and shifting clinical priorities. Healthcare systems around the world are increasingly focusing on efficiency, outcomes, and cost control, which has elevated the importance of technologies that can streamline procedures and improve patient recovery. This alignment between economic pressures and clinical needs is creating a favorable environment for the adoption of thrombus aspiration solutions.

Barriers to Optimization

Routine upfront use of thrombus aspiration has not been universally adopted, and this hesitation continues to act as a constraint on market growth. While the technique can be beneficial in selected cases, its routine application across all patients undergoing percutaneous coronary intervention (PCI) remains controversial due to mixed clinical outcomes and concerns about potential procedural risks. As a result, many clinicians prefer a more selective or bailout approach rather than incorporating aspiration as a standard first-line step in every case.

Detailed Market Segmentation

By product type, manual aspiration catheters accounted for the largest share of the thrombus aspiration catheter market in 2025, contributing approximately 41% of total revenue. Their leading position is largely attributed to their simplicity, cost-effectiveness, and widespread adoption in routine interventional procedures. These devices are commonly used in emergency and bailout situations where rapid thrombus removal is required, making them a practical choice for many healthcare providers.

By application, the acute coronary syndrome (ACS) segment accounted for a significant share of 44.50% of the thrombus aspiration catheter market in 2025. This strong position is primarily due to the high clinical urgency and prevalence of ACS conditions, which include ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina. These conditions are closely associated with sudden blockage of coronary arteries, making rapid and effective thrombus management a critical component of treatment.

By end use, hospitals accounted for the largest share of the thrombus aspiration catheter market in 2025, contributing approximately 56% of total revenue. This leading position is largely driven by the critical role hospitals play in managing acute and life-threatening thrombotic conditions such as myocardial infarction, stroke, and pulmonary embolism. These emergencies require immediate intervention, and hospitals are uniquely equipped to provide continuous, round-the-clock care supported by specialized infrastructure and multidisciplinary medical teams.

Segment Breakdown

By Product Type

  • Manual Aspiration Catheters
  • Mechanical Aspiration Catheters
  • Powered Aspiration Catheters

By Application

  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Ischemic Stroke
  • Others

By End-Use

  • Hospitals
  • Cardiovascular Centers
  • Ambulatory Surgical Centers (ASCs)
  • Others

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America held the leading position in the thrombus aspiration catheter market in 2025, accounting for a substantial 37.16% share. This dominance is not coincidental but stems from well-established structural strengths within the healthcare systems of the United States and Canada. These countries benefit from advanced medical infrastructure, widespread access to specialized care, and a strong emphasis on interventional cardiology procedures, all of which contribute to consistent demand for thrombus aspiration technologies.
  • A key driver behind this market leadership is the high volume of percutaneous coronary intervention (PCI) procedures performed annually in the United States, which is estimated at around 1.2 million. This significant procedural volume creates a steady and predictable need for aspiration catheters, ensuring continuous product utilization and turnover. Hospitals and cardiac centers are therefore more inclined to maintain robust inventories, further reinforcing market growth.

Leading Market Participants

  • AMG International
  • Biotronik
  • Endocor
  • Eucatech
  • HEXACATH
  • Medtronic Inc.
  • Nipro
  • SAI Infusion Technologies
  • Stentys
  • Teleflex
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Thrombus Aspiration Catheter Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Thrombus Aspiration Catheter Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers (Medical-grade Polymers, Metals)
    • 3.1.2. Component Manufacturers (Catheter Tubing, Guidewires, Tips)
    • 3.1.3. Medical Device Manufacturers (Design & Assembly)
    • 3.1.4. Distributors & Healthcare Suppliers
    • 3.1.5. Hospitals & Cardiac Centers
    • 3.1.6. Regulatory Authorities (FDA, EMA, CDSCO)
    • 3.1.7. End Users (Hospitals, Clinics, Ambulatory Surgical Centers)
  • 3.2. Industry Outlook
    • 3.2.1. Rising Prevalence of Cardiovascular Diseases (CVDs)
    • 3.2.2. Increasing Number of Percutaneous Coronary Interventions (PCI)
    • 3.2.3. Growing Adoption of Minimally Invasive Procedures
    • 3.2.4. Technological Advancements in Catheter Design
    • 3.2.5. Increasing Demand for Rapid Clot Removal Devices
    • 3.2.6. Expansion of Healthcare Infrastructure in Emerging Markets
    • 3.2.7. Rising Geriatric Population
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Dynamics and Trends
    • 3.5.1. Growth Drivers
      • 3.5.1.1. Increasing burden of thrombosis-related diseases driving demand
    • 3.5.2. Restraints
    • 3.5.3. Opportunity
    • 3.5.4. Key Trend
  • 3.6. Market Growth and Outlook
    • 3.6.1. Market Revenue & Volume Estimates and Forecast (US$ Mn), 2020 - 2035
    • 3.6.2. Price Trend Analysis, by Feedstock

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking
  • 4.4. Startup Ecosystem Analysis
  • 4.5. M&A and Funding Landscape

Chapter 5. Global Thrombus Aspiration Catheter Market Analysis

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Manual Aspiration Catheters
      • 5.2.1.2. Mechanical Aspiration Catheters
      • 5.2.1.3. Powered Aspiration Catheters
    • 5.2.2. By Application
      • 5.2.2.1. Acute Coronary Syndrome (ACS)
      • 5.2.2.2. Pulmonary Embolism (PE)
      • 5.2.2.3. Deep Vein Thrombosis (DVT)
      • 5.2.2.4. Ischemic Stroke
      • 5.2.2.5. Others
    • 5.2.3. By End-Use
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Cardiovascular Centers
      • 5.2.3.3. Ambulatory Surgical Centers (ASCs)
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
        • 5.2.4.1.1. The U.S.
        • 5.2.4.1.2. Canada
        • 5.2.4.1.3. Mexico
      • 5.2.4.2. Europe
        • 5.2.4.2.1. Western Europe
          • 5.2.4.2.1.1. The UK
          • 5.2.4.2.1.2. Germany
          • 5.2.4.2.1.3. France
          • 5.2.4.2.1.4. Italy
          • 5.2.4.2.1.5. Spain
          • 5.2.4.2.1.6. Rest of Western Europe
        • 5.2.4.2.2. Eastern Europe
          • 5.2.4.2.2.1. Poland
          • 5.2.4.2.2.2. Russia
          • 5.2.4.2.2.3. Rest of Eastern Europe
      • 5.2.4.3. Asia Pacific
        • 5.2.4.3.1. China
        • 5.2.4.3.2. India
        • 5.2.4.3.3. Japan
        • 5.2.4.3.4. South Korea
        • 5.2.4.3.5. Australia & New Zealand
        • 5.2.4.3.6. ASEAN
          • 5.2.4.3.6.1. Indonesia
          • 5.2.4.3.6.2. Malaysia
          • 5.2.4.3.6.3. Thailand
          • 5.2.4.3.6.4. Singapore
          • 5.2.4.3.6.5. Rest of ASEAN
        • 5.2.4.3.7. Rest of Asia Pacific
      • 5.2.4.4. Middle East & Africa
        • 5.2.4.4.1. UAE
        • 5.2.4.4.2. Saudi Arabia
        • 5.2.4.4.3. South Africa
        • 5.2.4.4.4. Rest of MEA
      • 5.2.4.5. South America
        • 5.2.4.5.1. Argentina
        • 5.2.4.5.2. Brazil
        • 5.2.4.5.3. Rest of South America

Chapter 6. North America Thrombus Aspiration Catheter Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country

Chapter 7. Europe Thrombus Aspiration Catheter Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country

Chapter 8. Asia Pacific Thrombus Aspiration Catheter Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country

Chapter 9. Middle East & Africa Thrombus Aspiration Catheter Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country

Chapter 10. South America Thrombus Aspiration Catheter Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. AMG International
  • 11.2. Biotronik
  • 11.3. Endocor
  • 11.4. Eucatech
  • 11.5. Medtronic plc
  • 11.6. HEXACATH
  • 11.7. Nipro
  • 11.8. SAI Infusion Technologies
  • 11.9. Stentys
  • 11.10. Teleflex
  • 11.11. Boston Scientific Corporation
  • 11.12. Terumo Corporation
  • 11.13. Penumbra Inc.
  • 11.14. Teleflex Incorporated
  • 11.15. Edwards Lifesciences Corporation
  • 11.16. Abbott Laboratories
  • 11.17. Johnson & Johnson MedTech
  • 11.18. AngioDynamics Inc.
  • 11.19. Inari Medical Inc.
  • 11.20. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Macro-Economic Outlook/Indicators